Clinuvel Pharmaceuticals Ltd. (ASX:CUV)
Share Price and News


Company Profile:

CLINUVEL PHARMACEUTICALS LIMITED (ASX: CUV) is a global biopharmaceutical that is into development of SCENESSE (its proprietary first-in-class drug, as a photoprotective) to manage a range of UV and light related skin disorders and other products for treating genetic disorders.



Code : ASX:CUV Healthcare Company


Clinuvel Pharmaceuticals Ltd. (ASX:CUV) Latest News